IMPORTANCE Neuroinflammation may play a role in epilepsy. Translocator protein 18 kDa (TSPO), a biomarker of neuroinflammation, is overexpressed on activated microglia and reactive astrocytes. A preliminary positron emission tomographic (PET) imaging study using carbon 11 ([ 11 C])-labeled PBR28 in patients with temporal lobe epilepsy (TLE) found increased TSPO ipsilateral to seizure foci. Full quantitation of TSPO in vivo is needed to detect widespread inflammation in the epileptic brain.
R ecent data implicate neuroinflammation as both cause and consequence of disease in patients with epilepsy. Animal studies as well as surgical specimens from patients with drug-resistant temporal lobe epilepsy (TLE) suggest that inflammation plays a key role in pathophysiological processes. [1] [2] [3] [4] [5] Intermediates including interleukins (ILs), tumor necrosis factor α, nuclear factor-kappa B, and highmobility group box 1 protein are expressed and toll-like receptors are upregulated in animal models of epilepsy 6 ; they are also found in several pathological entities, including mesial temporal sclerosis (MTS), focal cortical dysplasia (FCD), and dysembroplastic neuroepithelial tumors. [7] [8] [9] [10] Activated microglia, reactive astrocytes, and inflammatory intermediates may contribute to hyperexcitability in seizure foci. 11 The process may be widespread; for instance, kainic acid-induced status epilepticus resulted in immediate microglial activation in injected hippocampus and delayed IL signaling in contralateral hemisphere. 12 Toll-like receptor and IL-1β
antagonists suppressed seizures in animal models. 5, 6 Corticotropin-stimulated endogenous corticosteroid release effectively treated infantile spasms. 5 Translocator protein 18 kDa (TSPO), a biomarker for neuroinflammation, has been studied in patients with epilepsy and animal models. Normally expressed at low levels in brain, TSPO is overexpressed on activated microglia and reactive astrocytes. 13 In rodent brain, uptake of TSPO ligands fluorine 18 PK11195 binding in patients with Rasmussen encephalitis or FCD, but not TLE. 21, 22 Moreover, the asymmetry in our study was small, and without correcting for radioactivity in plasma we could not determine whether other brain regions were affected. This study investigated whether TSPO is increased in regions distant from seizure foci by comparing the [ 11 C]PBR28 distribution volume (V T ) to free fraction (f p ) ratio (V T /f p ) from each hemisphere in patients with TLE with that of controls. We attempted to replicate previous findings of higher [ 11 C]PBR28 uptake ipsilateral than contralateral to seizure foci in a larger patient sample, using more rigorous delineation of cortical regions. Patients were referred to the Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health. All were evaluated with ictal video electroencephalographic monitoring as well as 3-T Philips magnetic resonance imaging (MRI) with fluid-attenuated inversion recovery, T1-weighted (spin-echo and 3-dimensional magnetization-prepared rapid-acquisition gradient-echo), and T2-weighted sequences. Six patients subsequently had surgery. Patients were classified based on electroencephalographic findings, structural lesions on MRI, or surgical pathology (eTable 2 in the Supplement).
A recently discovered rs6971 polymorphism on the TSPO gene affects the binding affinity of second-generation TSPO PET ligands. The high (H)-and low (L)-affinity alleles are codominantly inherited, resulting in 3 genotypes: high-affinity binders (HABs; genotype HH), mixed-affinity binders (MABs; genotype HL), and low-affinity binders (genotype LL). To account for TSPO genotype, we determined each participant's affinity status using in vitro TSPO binding assays from leukocytes, 23 
Image Analysis
Brain regions were delineated using FreeSurfer software version 5.1.1 (http://surfer.nmr.mgh.harvard.edu) as previously described. 16 Briefly, T1-weighted MRIs were resliced to 1-mm isovoxel space and then corrected for inhomogeneity, processed for skull stripping, and segmented into gray and white matter according to the intensity gradient and connectivity of voxels. Misclassified voxels were corrected by minimal manual work. Cortical gray matter structures were parcellated with a probabilistic labeling algorithm by inflating the gray matter-white matter boundary and overlaying curvature information on the inflated surface. Subcortical structures were segmented and labeled by probabilistic registration technique. The probabilistic mask was applied to PET images coregistered to T1-weighted MRI resliced into isovoxel space. Decay-corrected radioactivity was measured in 42 regions (separated into left and right).
Measurement of Brain Uptake and Distribution Volume
To detect bilateral TSPO increases, we compared [
V T /f p between patients with TLE and controls. Formal quantitation of [ 11 C]PBR28 binding in brain requires correction for plasma concentration. Therefore, we calculated V T in 11 patients with TLE and 11 controls by fitting brain and plasma timeactivity curves to a 2-tissue compartment model as previously described. 16 Following consensus nomenclature for reversibly binding radioligands, V T is the brain to plasma radioligand concentration equilibrium ratio and is also the sum of specific (V S ) and nondisplaceable (V ND ) uptake. 24 Because only free ligand enters brain, we used the V T to f P ratio as our primary outcome measure. 23 We then compared genotype-corrected V T /f P in ipsilateral and contralateral regions from patients with TLE with left and right, respectively, from controls. To determine whether TSPO was increased in seizure foci, we compared ipsilateral and contralateral brain radioligand uptake for each ligand using averaged standardized uptake values (SUVs), which correct for body weight and injected activity, from 40 to 90 minutes after injection. To compare the 2 ligands, regional asymmetry indices (AIs) were calculated from SUVs: 200% × [(ipsilateral − contralateral)/(ipsilateral + contralateral)]. We compared left and right regional ligand uptake in controls to exclude physiological asymmetry.
Statistical Analysis
Data were normally distributed and are summarized as mean (standard deviation). The primary analysis was repeatedmeasures analysis of variance, with region as within-subjects factor and group as between-subjects factor, to compare V T /f P between patients with TLE and controls in ipsilateral and contralateral regions separately. This analysis tests the main hypothesis of inflammation throughout the ipsilateral and contralateral hemispheres. It gains statistical sensitivity by investigating all regions simultaneously. Significant main effects of group were followed by regional t tests without correction for multiple comparisons. Because they are only assessed after demonstrating a significant main effect of overall ipsilateral or contralateral inflammation, significant post hoc contrasts are unlikely to represent false-positive findings. Patients with TLE with and without MTS were compared using t tests. We used within-subjects paired-samples t tests to compare ipsilateral and contralateral [ 
Results

[ 11 C]PBR28 Binding in Patients With TLE and Controls
The V T /f P values were significantly higher in patients with TLE than controls in temporal and extratemporal regions ipsilateral (main effect of group: F 1,20 = 5.7; P = .03) and contralateral (F 1,20 = 4.4; P < .05) to seizure foci ( Figure 1 ). In the ipsilateral hemisphere, patients with TLE had 27% to 42% higher [
11 C]PBR28 V T /f P values than controls in 6 temporal regions and in thalamus (all P < .05). Increases seen in cerebellum, frontal and occipital cortices, and striatum were not significant (.05 < P < .08).
In the contralateral hemisphere, patients with TLE had approximately 28% higher V T /f P values in temporal regions; results were significant in hippocampus (P = .04), amygdala (P = .02), and temporal pole (P = .04) and not significant in fusiform gyrus, temporal cortex, and entorhinal cortex/ parahippocampal gyrus (all .05 < P < .06). The V T /f P values were We investigated whether separate ipsilateral and contralateral SUV measurements (as opposed to ipsilateral vs contralateral asymmetry) could substitute for V T /f P , obviating the need for blood sampling. In contrast to V T /f P , SUVs did not significantly differ between patients with TLE who had blood sampling and controls (mean of 6 regions; mean . Using a reference region by calculating regional to cerebellar SUV ratios revealed no significant group differences (mean for patients with TLE vs controls, ipsilateral: 1.1 vs 1.0, respectively; contralateral: 1.1 vs 1.0, respectively), except in ipsilateral temporal cortex (t = −2.8; P = .01).
Asymmetry of [ 11 C]PBR28 and [ 11 C]DPA-713 Uptake
Patients with TLE had higher [ ]PBR28 uptake ranged from 2% higher in fusiform gyrus and temporal cortex to 6% higher in amygdala. Mean differences were significant in hippocampus (t = 4.6; P < .001), amygdala (t = 4.2; P < .001), fusiform gyrus (t = 2.2; P = .04), and entorhinal cortex/parahippocampal gyrus (t = 3.1; P = .006) but not in temporal cortex (t = 1.5; P = .14) or pole (t = 2.0; P = .06). No significant left-right difference was observed in controls.
Twelve patients with TLE, 10 of whom had MTS, showed asymmetry in hippocampus more than 2 SDs greater than the control mean. We asked whether hippocampal atrophy might reduce radioligand asymmetry and found an inverse correlation between ipsilateral to contralateral hippocampal volume ratio and [
11 C]PBR28 AIs (r = −0.5; P = .02).
The [
11 C]PBR28 AIs in hippocampus were significantly higher in patients with MTS than in patients without MTS (8% vs 2%, respectively; P = .02) but not in other regions. In contrast, V T / f P did not differ based on the presence of MTS. There were no significant effects of seizure frequency (generalized tonic-clonic: 713 uptake ranged from 4% higher in fusiform gyrus and temporal cortex to 9% higher in temporal pole ( Figure 2 ). Mean differences were significant in hippocampus (t = 2.6; P = .03), amygdala (t = 3.4; P = .01), fusiform gyrus (t = 2.5; P = .04), entorhinal cortex/parahippocampal gyrus (t = 2.8; P = .03), and temporal pole (t = 3.1; P = .02) but not in temporal cortex (t = 2.4; P = .05). Controls had a small but significant difference in 
Discussion
We found increased TSPO in patients with TLE, extending beyond the seizure focus and involving bilateral regions. By using an automated brain segmentation procedure, we obviated observer bias inherent in the manual segmentation used in our prior study and reduced potential spillover from the choroid plexus. 17 We detected relative TSPO binding increases with [ Taken together, the data show that TSPO asymmetry in patients with TLE is a robust finding, independent of segmentation procedure and radioligand chemical class.
Elevated absolute [
11 C]PBR28 binding in regions distant from seizure foci suggests that inflammation in TLE is widespread, which may help explain low side-to-side binding asymmetry. Despite approximately 30% increases in V T /f P , SUVs did not significantly differ between patients with TLE and controls. Therefore, full quantitation with an arterial input function is likely required to detect widespread TSPO changes in vivo.
Hippocampal [ 11 C]PBR28 uptake asymmetry was significantly greater in patients with MTS than in those without MTS.
Expression of TSPO may be greater in MTS than other TLE pathological substrates. Moreover, increasing ipsilateral hippocampal volume loss predicted greater relative increases in ipsilateral [ 11 C]PBR28 uptake. This finding is particularly interesting, as hippocampal volume loss might have been predicted to reduce binding. However, volume loss reflects focal gliosis and neuronal loss. The ligand [
11 C]PBR28 is a glial rather than neuronal marker; thus, greater relative increases in ipsilateral binding may reflect increasing MTS pathological severity. The association between ipsilateral hippocampal atrophy and increased [ C]PBR28 lacks sensitivity to detect group differences in V T /f P , which contains noise from plasma data, and our cohort was small.
The V T corrected for f P is theoretically more accurate than V T alone because only free drug enters brain. Because it is a separate measurement, f P adds noise but may be important in epilepsy studies if antiepileptic drugs alter radioligand f P by plasma protein displacement. 25 We therefore chose V T /f P as our primary outcome measure. No patients were taking antiepileptic drugs with known anti-inflammatory effects.
Increased in vivo [
11 C](R)-PK11195 uptake in the affected hemisphere has been reported in a few patients with encephalitis and 1 patient with FCD. 21, 22 No changes in [ 11 C] (R)-PK11195 uptake were observed in hippocampal sclerosis, likely owing to a low specific to nonspecific binding ratio. Inflammation may lead to recurrent seizures in several ways. Altering glutamatergic and γ-aminobutyric acid-ergic neurotransmission may increase neuronal excitability. Proinflammatory cytokines are increased in various animal models of epilepsy, and their activation vs inactivation decreases and increases seizure threshold, respectively. 9, 27 These cytokines promote cell damage and excitotoxic effects, inhibit glutamate uptake, stimulate glutamatergic N-methyl-Daspartate receptors, and reduce γ-aminobutyric acid receptor function. 27 Seizure-related inflammation might contribute to cell loss and synaptic reorganization. In human mesial TLE and in epilepsy associated with FCD, IL-1β and IL receptor type 1 were expressed by astrocytes, microglia, and neurons. 4 In human MTS, astroglial, microglial, and neuronal complement component C1q, C3c, and C3d expression occurred in association with neuronal loss. 28 Inflammation may be linked to blood-brain barrier (BBB) alterations that can trigger seizures and lead to drug resistance. Disruption of the BBB in epilepsy models is associated with albumin deposition and IL-1β receptor activation. 2 Transforming growth factor β activation may play an important role in epileptogenesis after BBB compromise. 29 Neuroinflammation may lead to antiepileptic drug resistance by upregulating efflux transporters at the BBB. 30 In addition, bilateral inflammation might help explain the failure of temporal lobectomy to achieve seizure freedom in more than 50% to 60% of patients, despite apparent well-localized seizure onset.
31
One limitation of our AI measurements is that TSPO affinity status was not determined in patients with TLE from the prior study, which was completed before the polymorphism was discovered. To estimate the effects of TSPO genotype on [ Disruption of the BBB near seizure foci could allow greater radiometabolite brain entry and inflate observed TSPO asymmetry. However, in vitro autoradiography studies demonstrate TSPO overexpression in surgical tissue from patients with TLE. 15 Also, we found absolute TSPO increases contralateral to seizure foci, where the BBB should be intact. Spillover from the choroid plexus might contaminate signal in adjacent regions. We minimized the effect by separating the choroid plexus with FreeSurfer software and found almost symmetric [ 11 C]PBR28 uptake (mean AI, −1%), in contrast to significant asymmetry in hippocampus. Moreover, some areas were too distant (up to 4 cm) to be affected by choroid plexus signal (point spread function, GE camera: 0.7 cm). We found increased absolute TSPO binding in extratemporal regions in patients with TLE compared with controls.
Conclusions
This study demonstrates that patients with TLE have increased TSPO in both temporal lobes and extratemporal regions and confirms that the effect is most pronounced in temporal regions ipsilateral to seizure foci and in patients with MTS. These findings suggest a role for neuroinflammation in TLE and support development of anti-inflammatory approaches to treating drug-resistant epilepsy. 
